Voyager (VYGR) Climbs 6.45% on June 23

Equities Staff  |

Voyager Therapeutics Inc (NASDAQ: VYGR) has risen $0.32 (6.45%) and sits at $5.26, as of 12:13:16 est on June 23.

159,041 shares have exchanged hands.

The Company has increased 0.61% over the last 5 days and shares have fallen 19.09% over the last 30 days.

Voyager anticipates its next earnings on 2022-08-08.

For technical charts, analysis, and more on Voyager visit the company profile.

About Voyager Therapeutics Inc

Voyager Therapeutics is a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases. Voyager is committed to advancing the field of AAV gene therapy through innovation and investment in vector engineering and optimization, manufacturing, and dosing and delivery techniques. Voyager's wholly owned and partnered pipeline focuses on severe neurological diseases for which effective new therapies are needed, including Parkinson's disease, Huntington's disease, Friedreich's ataxia, and other severe neurological diseases.

To get more information on Voyager Therapeutics Inc and to follow the company's latest updates, you can visit the company's profile page here: Voyager Therapeutics Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade
What You Need To Know About Bear Markets



Market Movers

Sponsored Financial Content